Seqens – API Manufacturing Capabilities

PCI is a fully integrated Active Pharmaceutical Ingredient (API) manufacturer and custom synthesis supplier. We’ll be with you every step of the way as you develop your final API or chemical product.

Posted: April 6, 2017

Author:
Tags: API Manufacturing | Video
API Manufacturing and Pharmaceutical Manufacturing

 

Related posts:

How to Control Impurities during API drug manufacturing
PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2019
Internal Auditing – The Belt and Suspenders Approach to Quality in API Manufacturing
Seqens North America Honored with CMO Leadership Award for Reliability – Part 1
Seqens CDMO North America Honored for Service Excellence for 6th Straight Year

About the Author

Ed Price CEO of PCI Synthesis
Ed is President & CEO of SEQENS North America (formerly PCI Synthesis). He serves as a co-chair of the New England CRO/CMO Council and sits on the Industrial Advisory Board for the Department of Chemical Engineering at UMass, Amherst. Ed is also a long standing member of the American Chemical Society and advises the Bulk Pharmaceutical Task Force of the Society of Chemical Manufacturer’s and Affiliates (SOCMA)...

Do you have questions? Talk to Ed.